Low! Cinda bio "Beval Pearl Singtag" pricing announced.

On July 10, the Shaanxi Provincial Public Resources Trading Center released the "Public Ity on Newly Approved Drug-Related Information" and published information on 25 drugs that comply with newly approved drugs, including the recently listed Cinda Biobelavabead SINGA, with a price of 1188 yuan/bottle (4ml: 100mg).
June 19, Cinda Biopharmaceuticals (Suzhou) Co., Ltd.'s Bevalzhu monoto-injection injection was approved for listing, Cinda Bio became the second domestic biosimilar drug in China after Qilu Pharmaceuticals approved the second enterprise.
bevabead suprem is a humanized monoclonal antibody IgG1 prepared by recombinant DNA technology, which inhibits the binding of human endothelial growth factor (VEGF) with its receptors, inhibits tumor cell growth, and is used in the treatment of a variety of malignant tumors.
Roche Beval-Sing was approved in China in 2010 with a product called Anvitin.
July 2017, Roche Anvitin negotiated access to the national health insurance catalog, from 5223 yuan/ bottle to 1998 yuan/bottle, 2019 health insurance negotiations, a further reduction of 24.92 percent, at 1500 yuan per bottle price into the national health insurance.
December 2019, Qilu Pharmaceutical's Bevalu zuma ninth-dose injection was successfully launched as the first approved Avastin biosimilar drug in China, with a price of 1266 yuan per bottle and a price reduction of 1198 yuan per bottle.
.